Bill Text: TX HB4801 | 2023-2024 | 88th Legislature | Introduced

---

Bill Title: Relating to the use of the money in the Opioid Abatement Account.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2023-03-23 - Referred to Public Health [HB4801 Detail]

Download: Texas-2023-HB4801-Introduced.html

---

88R15237 JSC-D
By: Talarico H.B. No. 4801

A BILL TO BE ENTITLED
AN ACT
relating to the use of the money in the Opioid Abatement Account.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. Section 403.505(d), Government Code, is amended
to read as follows:
(d) A state agency may use money appropriated from the
account only to:
(1) prevent opioid use disorder through
evidence-based education and prevention, such as school-based
prevention, early intervention, or health care services or programs
intended to reduce the risk of opioid use by school-age children;
(2) support efforts to prevent or reduce deaths from
opioid overdoses or other opioid-related harms, including through
increasing the availability or distribution of naloxone or other
opioid antagonists for use by health care providers, first
responders, persons experiencing an opioid overdose, families,
schools, community-based service providers, social workers, or
other members of the public;
(3) create and provide training on the treatment of
opioid addiction, including the treatment of opioid dependence with
each medication approved for that purpose by the United States Food
and Drug Administration, medical detoxification, relapse
prevention, patient assessment, individual treatment planning,
counseling, recovery supports, diversion control, and other best
practices;
(4) provide opioid use disorder treatment for youths
and adults, with an emphasis on programs that provide a continuum of
care that includes screening and assessment for opioid use disorder
and co-occurring behavioral health disorders, early intervention,
contingency management, cognitive behavioral therapy, case
management, relapse management, counseling services, and
medication-assisted treatments;
(5) provide patients suffering from opioid dependence
with access to all medications approved by the United States Food
and Drug Administration for the treatment of opioid dependence and
relapse prevention following opioid detoxification, including
opioid agonists, partial agonists, and antagonists;
(6) support efforts to reduce the abuse or misuse of
addictive prescription medications, including tools used to give
health care providers information needed to protect the public from
the harm caused by improper use of those medications;
(7) support treatment alternatives that provide both
psychosocial support and medication-assisted treatments in areas
with geographical or transportation-related challenges, including
providing access to mobile health services and telemedicine,
particularly in rural areas;
(8) address:
(A) the needs of persons involved with criminal
justice; and
(B) rural county unattended deaths; [or]
(9) purchase opioid antagonists in bulk from
manufacturers to decrease the price burden on organizations
distributing opioid antagonists to respond to opioid overdoses; or
(10) further any other purpose related to opioid
abatement authorized by appropriation.
SECTION 2. This Act takes effect immediately if it receives
a vote of two-thirds of all the members elected to each house, as
provided by Section 39, Article III, Texas Constitution. If this
Act does not receive the vote necessary for immediate effect, this
Act takes effect September 1, 2023.